Ocular and Systemic Pharmacokinetics Of Latanoprost in Humans
- 1 August 2002
- journal article
- Published by Elsevier BV in Survey of Ophthalmology
- Vol. 47, S6-S12
- https://doi.org/10.1016/s0039-6257(02)00302-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The prostaglandin transporter is widely expressed in ocular tissuesSurvey of Ophthalmology, 1997
- Development of a radioimmunoassay for latanoprost and its application in a long-term study in monkeysProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitroProstaglandins, Leukotrienes & Essential Fatty Acids, 1994
- Phenyl-substituted prostaglandins: potent and selective antiglaucoma agentsJournal of Medicinal Chemistry, 1993
- Presence of a 15-Ketoprostaglandin Delta13-Reductase in Porcine Cornea.Acta Chemica Scandinavica, 1992
- Phenyl substituted prostaglandin analogs for glaucoma treatmentDrugs of the Future, 1992
- Content and formation of prostaglandins and distribution of prostaglandin-related enzyme activities in the rat ocular systemBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Inactivation of prostaglandin E1 by ocular tissues in vitroExperimental Eye Research, 1974
- Intraocular fluid dynamics. III. The site and mechanism of prostaglandin transfer across the blood intraocular fluid barriersExperimental Eye Research, 1972
- Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitroThe Journal of Physiology, 1972